EyePoint Pharmaceuticals logo
EyePoint Pharmaceuticals EYPT
$ 7.16 0.49%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

EyePoint Pharmaceuticals EV/EBITDA Ratio 2011-2024 | EYPT

Annual EV/EBITDA Ratio EyePoint Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.47 -4.17 -4.87 -3.3 -1.44 -5.06 13.7 -8.61 -7.14 -6.93 -11.8

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
13.7 -11.8 -4.01